{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:16:09Z","timestamp":1792343769211,"version":"4.4.0"},"reference-count":34,"publisher":"Galenos Yayinevi","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Surg"],"accepted":{"date-parts":[[2022,2,21]]},"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> The correlation between lymphedema severity and stages determined by standard diagnostic methods and Bioimpedance Spectroscopy (BIS) technique was examined in breast cancer-related lymphedema (BCRL) patients.<\/jats:p>\n                    <jats:p><jats:bold>Material and Methods:<\/jats:bold> The bioimpedance analyzer device was connected to the 1.0 cm disc electrodes which were connected to the affected and unaffected (healthy) arm of the patients. We evaluated the performance of the impedance (Z) at multiple frequencies (5-50-100-200 kHz) and phase angle (PA), resistance (R), and reactance (XC) at 50 kHz on the lymphedema severity and stages. Bioimpedance measurements were applied to all volunteers in cooperation with the Physical Therapy and Rehabilitation Department. In this study, the correlation between BCRL severity and stages and bioimpedance values was examined.<\/jats:p>\n                    <jats:p><jats:bold>Results:<\/jats:bold> A total of 31 female patients were recruited to compare the BIS technique with standard diagnostic techniques. The severity of lymphedema was found among the patients as follows; mild 14 (45.2%), moderate 10 (32.3%), and severe 7 (22.6%). The stage distribution of volunteers was; 15 (48.4%) patients in Stage 0, 10 (32.3%) patients in Stage 1, 5 (16.1%) patients in Stage 2, and 1 (3.2%) patient in Stage 3. The ratio of affected and unaffected arm bioimpedance mean values were calculated. Although, this ratio at 50-100-200 kHz Z and 50kHz R were significantly correlated with the lymphedema stages (p&lt; 0.05), there was no correlation and significant difference between the ratio of the bioimpedance values and lymphedema severity (p&gt; 0.05).<\/jats:p>\n                    <jats:p><jats:bold>Conclusion:<\/jats:bold> The BIS technique is timesaving and can determine lymphedema stages. We found a significant correlation between BCRL stages and BIS, and it appears that BIS is an appropriate, inexpensive, simple, and noninvasive technique for detecting the stages of BCRL.<\/jats:p>","DOI":"10.47717\/turkjsurg.2022.5550","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:28:06Z","timestamp":1648567686000},"page":"11-17","source":"Crossref","is-referenced-by-count":5,"title":["The role of bioimpedance spectroscopy method in severity and stages of breast cancer-related lymphedema"],"prefix":"10.47717","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-3340","authenticated-orcid":false,"given":"T\u00fcrkan","family":"Turgay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-5410","authenticated-orcid":false,"given":"Tuba","family":"Denk\u00e7eken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-7102","authenticated-orcid":false,"given":"G\u00f6kt\u00fcrk","family":"Maralcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 2021; 71(3): 209-49. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 2018; 7(4): 379-403. https:\/\/doi.org\/10.21037\/gs.2017.11.04","DOI":"10.21037\/gs.2017.11.04"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol 2017; 24(10): 2972-80. https:\/\/doi.org\/10.1245\/s10434- 017-5960-x","DOI":"10.1245\/s10434-017-5960-x"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett 2020; 19(3): 2085-96. https:\/\/doi.org\/10.3892\/ol.2020.11307","DOI":"10.3892\/ol.2020.11307"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. Arch Phys Med Rehabil 2011; 92(4): 603-10. https:\/\/doi.org\/10.1016\/j.apmr.2010.11.017","DOI":"10.1016\/j.apmr.2010.11.017"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg 2018; 71(7): 1041-50. https:\/\/doi.org\/10.1016\/j.bjps.2018.02.012","DOI":"10.1016\/j.bjps.2018.02.012"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Seward C, Skolny M, Brunelle C, Asdourian M, Salama L, Taghian AG. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema. J Surg Oncol 2016; 114(5): 537-42. https:\/\/doi.org\/10.1002\/jso.24365","DOI":"10.1002\/jso.24365"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Czerniec SA, Ward LC, Refshauge KM, Beith J, Lee MJ, York S, et al. Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report. Cancer Invest 2010; 28(1): 54-62. https:\/\/doi.org\/10.3109\/07357900902918494","DOI":"10.3109\/07357900902918494"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Executive Committee of the International Society of L. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53(1): 3-19. https:\/\/doi.org\/10.2458\/lymph.4649","DOI":"10.2458\/lymph.4649"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Krishnan GH, Nanda A, Natarajan RA. Synovial fluid density measurement for diagnosis of arthritis. Biomed Pharmacol J 2014; 7(1): 221-4. https:\/\/doi.org\/10.13005\/bpj\/476","DOI":"10.13005\/bpj\/476"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Baumgartner RN, Chumlea WC, Roche AF. Bioelectric impedance phase angle and body composition. Am J Clin Nutr 1988; 48(1): 16-23. https:\/\/doi.org\/10.1093\/ajcn\/48.1.16","DOI":"10.1093\/ajcn\/48.1.16"},{"key":"ref-12","unstructured":"Released IC. IBM SPSS Statistics for Windows Version 23.0. Version 23.0 ed. Armonk, NY: IBM Corp.2013."},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, et al. Reducing Breast Cancer-Related Lymphedema (BCRL) through prospective surveillance monitoring using Bioimpedance Spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol 2018; 25(10): 2948-52. https:\/\/doi.org\/10.1245\/s10434-018-6601-8","DOI":"10.1245\/s10434-018-6601-8"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Polat AK, Karabacak U, Mutlu V, Tomak L, Bilgici A. Early diagnosis of lymphedema after breast cancer treatment: bio-\u0131mpedance spectroscopy. J Breast Health 2017; 13(2): 83-7. https:\/\/doi.org\/10.5152\/tjbh.2016.3357","DOI":"10.5152\/tjbh.2016.3357"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Erdogan Iyigun Z, Selamoglu D, Alco G, Pilanci KN, Ordu C, Agacayak F, et al. Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the florence nightingale breast study group. Lymphat Res Biol 2015; 13(1): 40-5. https:\/\/doi.org\/10.1089\/lrb.2014.0014","DOI":"10.1089\/lrb.2014.0014"},{"key":"ref-16","unstructured":"Boccardo FM, Ansaldi F, Bellini C, Accogli S, Taddei G, Murdaca G, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology 2009; 42(1): 1-9."},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Zou L, Liu FH, Shen PP, Hu Y, Liu XQ, Xu YY, et al. The incidence and risk factors of related lymphedema for breast cancer survivors postoperation: a 2-year follow-up prospective cohort study. Breast Cancer 2018; 25(3): 309-14. https:\/\/doi.org\/10.1007\/s12282-018-0830-3","DOI":"10.1007\/s12282-018-0830-3"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Turgay T, G\u00fcnel Karadeniz P, Maralcan G. Quality of life for women with breast cancer-related lymphedema: the \u0131mportance of collaboration between physical medicine and rehabilitation and general surgery clinics. Arch Breast Cancer 2021; 8(2): 119-26. https:\/\/doi.org\/10.32768\/abc.202182119-126","DOI":"10.32768\/abc.202182119-126"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"McDuff SGR, Mina AI, Brunelle CL, Salama L, Warren LEG, Abouegylah M, et al.Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys 2019; 103(1): 62- 70. 2018\/08\/31. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.036","DOI":"10.1016\/j.ijrobp.2018.08.036"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Asdourian MS, Swaroop MN, Sayegh HE, Brunelle CL, Mina AI, Zheng H, et al. Association between precautionary behaviors and breast cancer-related lymphedema in patients undergoing bilateral surgery. J Clin Oncol 2017; 35(35): 3934-41. https:\/\/doi.org\/10.1200\/JCO.2017.73.7494","DOI":"10.1200\/JCO.2017.73.7494"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"Iyigun ZE, Duymaz T, Ilgun AS, Alco G, Ordu C, Sarsenov D, et al. Preoperative lymphedema-related risk factors in early-stage breast cancer. Lymphat Res Biol 2018; 16(1): 28-35. https:\/\/doi.org\/10.1089\/lrb.2016.0045","DOI":"10.1089\/lrb.2016.0045"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Armer J, Fu MR. Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs 2005; 28(3): 200-7; quiz 208-9. https:\/\/doi.org\/10.1097\/00002820-200505000-00007","DOI":"10.1097\/00002820-200505000-00007"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 2003; 79(1): 47-57. https:\/\/doi.org\/10.1023\/A:1023330206021","DOI":"10.1023\/A:1023330206021"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Swaroop MN, Ferguson CM, Horick NK, Skolny MN, Miller CL, Jammallo LS, et al. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort. Breast Cancer Res Treat 2015; 151(2): 393-403. https:\/\/doi.org\/10.1007\/s10549-015-3408-1","DOI":"10.1007\/s10549-015-3408-1"},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"Cariati M, Bains SK, Grootendorst MR, Suyoi A, Peters AM, Mortimer P, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. Br J Surg 2015; 102(9): 1071-8. https:\/\/doi.org\/10.1002\/bjs.9846","DOI":"10.1002\/bjs.9846"},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med 2018; 379(20): 1937-44. https:\/\/doi.org\/10.1056\/NEJMcp1803290","DOI":"10.1056\/NEJMcp1803290"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Pappalardo M, Starnoni M, Franceschini G, Baccarani A, De Santis G. Breast cancer-related lymphedema: recent updates on diagnosis, severity and available treatments. J Pers Med 2021; 11(5). https:\/\/doi.org\/10.3390\/jpm11050402","DOI":"10.3390\/jpm11050402"},{"key":"ref-28","unstructured":"Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 2001; 34(1): 2-11."},{"key":"ref-29","doi-asserted-by":"crossref","unstructured":"Ward LC. Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol 2006; 4(1): 51-6. https:\/\/doi.org\/10.1089\/lrb.2006.4.51","DOI":"10.1089\/lrb.2006.4.51"},{"key":"ref-30","doi-asserted-by":"crossref","unstructured":"Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol 2014; 12(4): 289-94. https:\/\/doi.org\/10.1089\/lrb.2014.0035","DOI":"10.1089\/lrb.2014.0035"},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, et al. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology 2013; 46(2): 85-96. https:\/\/doi.org\/10.1158\/0008-5472.SABCS13-P2-11-17","DOI":"10.1158\/0008-5472.SABCS13-P2-11-17"},{"key":"ref-32","doi-asserted-by":"crossref","unstructured":"Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, et al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008; 8: 249. https:\/\/doi.org\/10.1186\/1471- 2407-8-249","DOI":"10.1186\/1471-2407-8-249"},{"key":"ref-33","doi-asserted-by":"crossref","unstructured":"Tuorkey MJ. Bioelectrical impedance as a diagnostic factor in the clinical practice and prognostic factor for survival in cancer patients: prediction, accuracy and reliability. J Biosens Bioelectron 2012; 3(4). https:\/\/doi.org\/10.4172\/2155-6210.1000121","DOI":"10.4172\/2155-6210.1000121"},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Guofeng Q, Wei W, Wei D, Fan Z, Sinclair AJ, Chatwin CR. Bioimpedance analysis for the characterization of breast cancer cells in suspension. IEEE Trans Biomed Eng 2012; 59(8): 2321-9. https:\/\/doi.org\/10.1109\/TBME.2012.2202904","DOI":"10.1109\/TBME.2012.2202904"}],"container-title":["Turkish Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/turkjsurg.com\/full-text-pdf\/1827\/eng","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/turkjsurg.com\/full-text-pdf\/1827\/eng","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T06:06:00Z","timestamp":1741068360000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjsurg.com\/articles\/doi\/turkjsurg.2022.5550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.47717\/turkjsurg.2022.5550","relation":{},"ISSN":["2564-6850","2564-7032"],"issn-type":[{"value":"2564-6850","type":"print"},{"value":"2564-7032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}